Fulgent Genetics, Inc. (NASDAQ:FLGT) Q2 2021 Earnings Conference Call August 9, 2021 4:30 PM ET
Company Participants
Nicole Borsje - Investor Relations
Ming Hsieh - Chief Executive Officer
Larry Weiss - Chief Medical Officer
Brandon Perthuis - Chief Commercial Officer
Paul Kim - Chief Financial Officer
Conference Call Participants
Kevin DeGeeter - Oppenheimer
Steven Mah - Piper Sandler
Katie Tryhane - Crédit Suisse
Operator
Good day, and welcome to the Fulgent Genetics 2Q 2021 Earnings Conference Call.
At this time, I would like to turn the conference over to Nicole Borsje with Investor Relations. Please go ahead.
Nicole Borsje
Great. Thanks. Good afternoon, and welcome to the Fulgent Genetics Second Quarter 2021 Financial Results Conference Call. On the call today are Ming Hsieh, Chief Executive Officer; Paul Kim, Chief Financial Officer; Dr. Larry Weiss, Chief Medical Officer; and Brandon Perthuis, the company's Chief Commercial Officer. The company's press release discussing its financial results is available in the Investor Relations section of the company's website Fulgent Genetics – ir.fulgentgenetics.com. An audio replay of this call will be available shortly after the call concludes. Please visit the Investor Relations section of the company's website to access the audio replay.
Management's prepared remarks and answers to your questions on today's call will contain forward-looking statements. These forward-looking statements represent management's estimates based on current views and assumptions, which may prove to be incorrect. As a result, matters discussed in any forward-looking statements are subject to risks, uncertainties and changes in circumstances that may cause actual results to differ from those described in the forward-looking statements.
The company assumes no obligation to update any of the forward-looking statements it may make today to reflect actual results or changes in expectations. Listeners should not rely on any forward-looking statements as predictions of future events and should
- Read more current FLGT analysis and news
- View all earnings call transcripts